Susquehanna International Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-74,496
| Closed | -$248K | – | 11308 |
|
|
2019
Q4 | $248K | Sell |
74,496
-109,333
| -59% | -$348K | ﹤0.01% | 8377 |
|
|
2019
Q3 | $559K | Buy |
183,829
+154,386
| +524% | +$434K | ﹤0.01% | 7044 |
|
|
2019
Q2 | $70K | Buy |
+29,443
| New | +$88K | ﹤0.01% | 9748 |
|
|
2019
Q1 | – | Sell |
-30,274
| Closed | -$113K | – | 10351 |
|
|
2018
Q4 | $109K | Buy |
+30,274
| New | +$132K | ﹤0.01% | 8178 |
|
|
2018
Q3 | – | Sell |
-25,210
| Closed | -$144K | – | 10698 |
|
|
2018
Q2 | $126K | Buy |
+25,210
| New | +$130K | ﹤0.01% | 8951 |
|
|
2018
Q1 | – | Sell |
-10,406
| Closed | -$62.6K | – | 10621 |
|
|
2017
Q4 | $63K | Buy |
+10,406
| New | +$62.6K | ﹤0.01% | 8848 |
|
|
2017
Q3 | – | Sell |
-16,887
| Closed | -$78K | – | 10005 |
|
|
2017
Q2 | $78K | Buy |
+16,887
| New | +$75.4K | ﹤0.01% | 8791 |
|
|
2017
Q1 | – | Sell |
-17,114
| Closed | -$165K | – | 10473 |
|
|
2016
Q4 | $190K | Buy |
+17,114
| New | +$161K | ﹤0.01% | 8686 |
|
|
2016
Q3 | – | Sell |
-13,448
| Closed | -$85K | – | 9342 |
|
|
2016
Q2 | $85K | Buy |
+13,448
| New | +$89.2K | ﹤0.01% | 8096 |
|
Susquehanna International Group's FOMX Position: Q1 2020 in Review
Susquehanna International Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 74,496 shares — an estimated $248K sold.
Susquehanna International Group first reported a position in FOMX in Q2 2016 and held it in 9 quarters. The position peaked at $559K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Susquehanna International Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Susquehanna International Group sold 74,496 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $248K.
- Susquehanna International Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2016 and held it in 9 quarters.
- Susquehanna International Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $559K in Q3 2019.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.